Article Text
Letter
HLA-DRB1*0901 lowers anti-cyclic citrullinated peptide antibody levels in Japanese patients with rheumatoid arthritis
Statistics from Altmetric.com
Footnotes
The first two authors contributed equally.
-
Funding This study was supported by a grant from CGM, RIKEN and a grant for Research on Intractable Diseases and Research on Human Genome Tailor-Made from the Ministry of Health, Labour and Welfare of Japan.
-
Competing interests None.
-
Patient consent Obtained.
-
Ethics approval Approved by the Ethical Committee of the BioBank Japan Project.
-
Provenance and peer review Not commissioned; externally peer reviewed.